Back to Search
Start Over
Cellular and gene therapy for major histocompatibility complex class II deficiency.
- Source :
-
News in Physiological Sciences . Jun2004, Vol. 19 Issue 3, p154-8. 5p. - Publication Year :
- 2004
-
Abstract
- Major histocompatibility complex (MHC) class II deficiency is a primary immunodeficiency. Lentiviral vectors are used for gene therapy in a mouse model of this disease. In addition, by a direct genetic correction approach, a diagnostic test to determine which of the four MHC II genes is defective in new MHC II-deficiency patients has been optimized. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 08861714
- Volume :
- 19
- Issue :
- 3
- Database :
- Academic Search Index
- Journal :
- News in Physiological Sciences
- Publication Type :
- Academic Journal
- Accession number :
- 16844073
- Full Text :
- https://doi.org/10.1152/nips.01462.2003